11/1/21

Risks of and From SARS-CoV-2 Infection and COVID-19 in People With Diabetes: a Systematic Review of Reviews   

Hartmann-Boyce J, Rees K, Perring JC, et al. | Diabetes Care

Aim: To review the evidence regarding the extent to which PWD are at increased risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and/or of suffering its complications, including associated mortality.

6/1/21

Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers: A Living Rapid Review   

Chou R, Dana T, Buckley D, et al. | Ann Intern Med

Aim: To examine the burden of SARS-CoV-2, SARS-CoV-1, and Middle Eastern respiratory syndrome (MERS)-CoV on HCWs and risk factors for infection, using rapid and living review methods.

4/27/21

Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults: A Living Systematic Review     

Mackey K, Kansagara D, Vela K | Ann Intern Med

Aim: To synthesize evidence on the role of ACE inhibitor and ARB use on patient outcomes in COVID-19 as well as evidence on the benefits and harms of initiating these medications to treat patients with COVID-19.

3/26/21

International travel-related control measures to contain the COVID-19 pandemic: a rapid review   

Burns J, Movsisyan A, Stratil JM, et al. | Cochrane Database Syst Rev

Aim: To assess the effectiveness of travel?related control measures during the COVID?19 pandemic on infectious disease and screening?related outcomes.

3/23/21

What are relevant, feasible and effective approaches to promote acceptance, uptake and adherence to physical distancing measures for COVID-19 prevention and control? 

Ryan RE, Parkhill A, Schonfeld L, et al. | Health Evidence Network

Aim: To analyse evidence regarding communication with individuals and communities within the wider structural and sociopolitical context of the pandemic to support public health decision-makers when planning and implementing physical distancing measures.

1/19/21

Adverse effects of non-steroidal anti-inflammatory drugs in patients with viral respiratory infections: rapid systematic review   

von Philipsborn P, Biallas R, Burns J, et al. | BMJ Open

Aim: To assess the effects of prior and current use of NSAIDs in patients with acute viral respiratory infections on acute severe adverse events , on acute healthcare utilization, as well as on quality of life and long-term survival.

9/18/20

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19   

WHO REACT Working Group | JAMA

Aim: To estimate the association between administration of corticosteroids compared with usual care or placebo and 28-day all-cause mortality.

9/14/20

Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review   

Nussbaumer-Streit B, Mayr V, Dobrescu AI, et al. | Cochrane Database of Systematic Reviews

Aim: To assess the effects of quarantine (alone or in combination with other measures) of individuals who had contact with confirmed cases of COVID19, who travelled from countries with a declared outbreak, or who live in regions with high transmission of the disease.

6/17/20

High-flow nasal cannula for acute hypoxemic respiratory failure in patients with COVID-19: systematic reviews of effectiveness and its risks of aerosolization, dispersion, and infection transmission   

Agarwal A, Basmaji J, Muttalib F, et al. | Can J Anaesth

Aim: To describe the efficacy and safety of HFNC in acute hypoxemic respiratory failure; and to determine the risk of dispersion, aerosol generation and associated transmission of COVID-19 with HFNC.

5/14/20

Safe management of bodies of deceased persons with suspected or confirmed COVID-19: a rapid systematic review   

Yaacoub S, Schunemann H, Khabasa J, et al. | BMJ Global Health

Aim: To systematically review the literature to scope and assess the effects of specific strategies for the management of the bodies.

4/30/20

Appropriate use of medical imaging in COVID-19 patients (ie.. chest X-ray, chest CT and lung utrasound) 

 | Cochrane COVID Rapid Reviews

4/27/20

Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective 

Halpin D, Singh D, Hadfield RM | Eur Respir J

Aim: To evaluate whether pre-morbid use or continued administration of inhaled steroids is a risk factor for adverse outcomes in acute respiratory infections due to COVID-19, SARS or MERS. 

4/19/20

The use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients with COVID-19 

 | WHO

Aim: To assess the effects of prior and current use of NSAIDs in patients with acute viral respiratory infections on acute severe adverse events , on acute health care utilization, as well as on quality of life and long-term survival.

4/16/20

Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID-19: initial assessment   

Ford N, Vitoria M, Rangaraj A, et al. | J Int AIDS Soc

Aim: To systematically review the clinical outcomes of using antiretroviral drugs for the prevention and treatment of coronaviruses and planned clinical trials.

4/15/20

What is the efficacy and acceptability of universal mask use by health care workers in health care settings in preventing respiratory infection during epidemics? 

Chou R, Dana T | Pacific Northwest Evidence-Based Practice Center

Aim: To inform evidence based guidance on universal mask use by HCWs in health care settings during the COVID-19 pandemic.

4/6/20

COVID and pregnancy: MTC transmission, outcomes 

Devane D | Cochrane COVID Rapid Reviews

4/6/20

Effectiveness of High Flow Nasal Cannula Therapy  

Vandvik PO | Cochrane COVID Rapid Reviews

4/6/20

Exposure, risk factors and epidemiology of healthcare worker infections with SARS-1, MERS, and SARS-COV-2 

Chou R | Cochrane COVID Rapid Reviews

4/6/20

What is the effectiveness of chloroquine and hydroxychloroquine for COVID-19? 

Reveiz L | Cochrane COVID Rapid Reviews

4/6/20

What is the effectiveness of interferon-?-1a for patients with moderate to severe acute respiratory distress syndrome? 

Reveiz L | Cochrane COVID Rapid Reviews

4/6/20

What is the effectiveness of remdesivir for COVID-19? 

Reveiz L | Cochrane COVID Rapid Reviews

4/6/20

What is the effectiveness of tocilizumab (IL-6 receptor blocker) for COVID-19? 

Reveiz L | PAHO

4/5/20

Physical distance from a known COVID-19 patient and droplet transmission; with and without mask use 

Akl E, Schunemann H | American University of Beirut Medical Center (protocol under development)

4/4/20

Corticosteroids in patients with COVID-19, SARS, MERS, influenza, community acquired pneumonia, or ARDS 

Ye Z, Guyatt G | McMaster University

4/1/20

What are relevant, acceptable, feasible approaches for rapid engagement and good participatory practice that includes communities in public health response? 

 | Centre for Health Communication and Participation

3/26/20

Quarantine: Individual and community for influenza 

Gartlehner G | Danube University (protocol under development)

3/25/20

What are the relevant, feasible, effective approaches to promote acceptance, uptake, and adherence to public health measures for COVID-19 prevention  

 | Centre for Health Communication and Participation

Noninvasive ventilation as an aerosol generating procedures  

Schunemann H | McMaster University